The European IVF Monitoring Programme (EIM) was established to collect, process and finally publish regional data for Europe on direct clinical results and side-effects, follow-up children's well-being and also the availability and the structure of services in the different countries.
The PGT Consortium of the European Society of Human Reproduction and Embryology comprises a group of expert members in Preimplantation Genetic Testing and Screening whose activities take place under the auspices of the Special Interest Group Reproductive Genetics.
The ESHRE grant rewards the best projects for scientists or clinicians with innovative research ideas in the field of human reproduction and embryology.
The genetic screening of fertilised eggs for embryo selection in assisted reproduction makes no difference to live birth rates, according to results from the largest published study of its kind. Results from this multicentre randomised controlled trial are reported in the journal Human Reproduction and, say the authors, confirm the "widely accepted" view that preimplantation genetic testing for chromosome abnormality (PGT-A) will not increase live birth rates in IVF.
Share this page